HCV NS3-NS4A protease resistance mutants

Details HCV NS3-NS4A protease resistance mutants HCV NS3-NS4A protease resistance mutants

2004-10-27

2009-02-24

Chen, Stacy B. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C536S023100

Reexamination Certificate

active

07494660

ABSTRACT:
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

REFERENCES:
patent: 4835168 (1989-05-01), Paget et al.
patent: 5484801 (1996-01-01), Al-Razzak et al.
patent: 5631128 (1997-05-01), Kozal et al.
patent: 5807876 (1998-09-01), Armistead et al.
patent: 5990276 (1999-11-01), Zhang et al.
patent: 6037157 (2000-03-01), Norbeck et al.
patent: 6054472 (2000-04-01), Armistead et al.
patent: 6127422 (2000-10-01), Colacino et al.
patent: 6162613 (2000-12-01), Su et al.
patent: 6344465 (2002-02-01), Armistead et al.
patent: 6489098 (2002-12-01), Petropoulos et al.
patent: 6498178 (2002-12-01), Stamos et al.
patent: 6541496 (2003-04-01), Armistead et al.
patent: 6608027 (2003-08-01), Tsantrizos et al.
patent: 6617130 (2003-09-01), Bogosian et al.
patent: 6617156 (2003-09-01), Doucette-Stamm et al.
patent: WO-94/14436 (1994-07-01), None
patent: WO-95/07696 (1995-03-01), None
patent: WO-95/09614 (1995-04-01), None
patent: WO-97/40028 (1997-10-01), None
patent: WO-97/43310 (1997-11-01), None
patent: WO-98/11134 (1998-03-01), None
patent: WO-98/17679 (1998-04-01), None
patent: WO-98/40381 (1998-09-01), None
patent: WO-98/46630 (1998-10-01), None
patent: WO-99/07733 (1999-02-01), None
patent: WO-99/07734 (1999-02-01), None
patent: WO-99/50230 (1999-10-01), None
patent: WO-99/64442 (1999-12-01), None
patent: WO-00/09543 (2000-02-01), None
patent: WO-00/09558 (2000-02-01), None
patent: WO-00/56331 (2000-09-01), None
patent: WO-00/59929 (2000-10-01), None
patent: WO-02/08244 (2002-01-01), None
patent: WO-02/18369 (2002-03-01), None
patent: WO-02/068933 (2002-09-01), None
Lin et al. Antimicrobial Agents and Chemotherapy, 2006, vol. 50, p. 1813-1822.
Alberti et al., J. Hepatol., 31 Suppl 1:17-24 (1999).
Alter et al., Gastroenterol. Clin. North Am., 23(3):437-455 (1994).
Alter, J. Hepatol., 31 Suppl 1:88-91 (1999).
Alter et al., Semin. Liver Dis., 20(1):17-35 (2000).
Barbato et al., J. Mol. Biol., 289(2):371-384 (1999).
Beyer et al., Proteins, 43(2):82-88 (2001).
Blight et al., Antivir. Ther., 3(Suppl 3):71-81 (1998).
Casbarra et al., Protein Sci., 11:2102-2112 (2002).
Chander et al., Hepatology, 36(5 Suppl 1):S135-S144 (2002).
Chena Nucleosides Nucleotides, 3:421-535 (1994) **Not Found**.
Choo et al., Science, 244:359-362 (1989).
Clayette et al., Pathol. Biol., 47(5):553-559 (1999).
Davis et al., N. Engl. J. Med., 339(21):1493-1499 (1998).
Davis et al., Semin. Liver Dis., 19 Suppl., 1:103-112 (1999).
De Francesco et al., Antiviral Res., 58(1):1-16 (2003).
De Francesco et al., Curr. Top. Microbiol. Immunol., 242:149-169 (2000).
Dunsdon et al., Bioorg. Med. Chem. Lett., 10(14):1577-1579 (2000).
Han et al., Bioorg. Med. Chem. Lett., 10(8):711-713 (2000).
Iwarson, FEMS Microbiol. Rev., 14(3):201-204 (1994).
Janssen et al., J. Hepatol., 21(2):241-243 (1994).
J. Viral. Hepat., “Global Surveillance and Control of Hepatitis,” 6(1):35-47 (1999).
Kao et al., J. Gastroenterol. Hepatol., 15(12):1418-1423 (2000).
Kenny-Walsh, Clin. Liver Dis., 5(4):969-977 (2001).
Kew, FEMS Microbiol. Rev., 14(3):211-219 (1994).
Kim et al., Biochem. Biophys. Res. Commun., 215(1):160-166 (1995).
Koch et al., Virology, 237:78-88 (1997).
Landro et al., Biochemistry, 36(31):9340-9348 (1997).
LaPlante et al., Bioorg. Med. Chem. Lett., 10(20):2271-2274 (2000).
Llinas-Brunet et al., Bioorg. Med. Chem. Lett., 8(13):1713-1718 (1998).
Llinas-Brunet et al., Bioorg. Med. Chem. Lett., 10(20):2267-2270 (2000).
McCoy et al., J. Mol. Biol., 305(5):1099-1110 (2001).
McHutchison et al., Hepatology, 36(5 Suppl 1):S245-S252 (2002).
McHutchinson et al., N. Engl. J. Med., 339(21):1485-1492 (1998).
Moradpour et al., Eur. J. Gastroenterol. Hepatol., 11(11):1199-1202 (1999).
Morrison, Biochim. Biophys. Acta, 185(2):269-286 (1969).
Reddy et al., Hepatology, 33(2):433-438 (2001).
Renault et al., Semin. Liver Dis., 9(4):273-277 (1989).
Rice, Field Virology Book, pp. 931-959 (1996).
Sauder, J. Am. Acad. Dermatol., 43(1 Pt 2):S6-S11 (2000).
Simon et al., Hepatology, 25(2):445-448 (1997).
Steinkuhler et al., Curr. Med. Chem., 8(8):919-932 (2001).
Taliani et al., Anal. Biochem., 240(1):60-67 (1996).
Tazulakhova et al., J. Interferon. Cytokine Res., 21(2):65-73 (2001).
Tsantrizos et al., Angew. Chem. Int. Ed. Engl.,42(12):1356-1360 (2003).
Vorgruggen, Acta Biochim. Pol., 43(1):25-36 (1996).
Wasley et al., Semin. Liver Dis., 20(1):1-16 (2000).
Weiland, FEMS Microbiol. Ev., 14(3):279-288 (1994).
Yao et al., Structure Fold Des., 7(11):1353-1363 (1999).
Younossi et al., Semin. Liver Dis., 19 Suppl 1:95-102 (1999).
Yun et al., Drug Metab. Dispos., 21(3):403-409 (1993).
Bartenschlager et al., J. Virol., 67(7):3835-3844 (1993).
Bartenschlager et al., J. Virol., 69(12):7519-7528 (1995).
Behrens et al., EMBO J., 15(1):12-22 (1996).
Blight et al., Science, 290:1972-1974 (2000).
Chambers et al., Proc. Natl. Acad. Sci. USA, 87:8898-8902 (1990).
Choo et al., Proc. Natl. Acad. Sci. USA, 88:2451-2455 (1991).
Colacino et al., Antimicrob. Agents Chemother., 34(11):2156-2163 (1990).
Di Marco et al., J. Biol. Chem., 275(10):7152-7157 (2000).
Failla et al., J. Virol., 69(3):1769-1777 (1995).
Frese et al., J. Gen. Virol., 82:723-733 (2001).
GenBank CAB46913 Science 285 110-113 (1999).
Grakoui et al., J. Virol., 67(3):1385-1395 (1993).
Grakoui et al., J. Virol., 67(5):2832-2843 (1993).
Grakoui et al., Proc. Natl. Acad. Sci. USA, 90:10583-10587 (1993).
Hijikata et al., Proc. Natl. Acad. Sci. USA, 90:10773-10777 (1993).
Hijikata et al., J. Virol., 67(8):4665-4675 (1993).
Hirsch et al., Clin. Infect. Dis., 37:113-128 (2003).
International Search Report in PCT/US2004/035839 dated Apr. 6, 2005.
Kato et al., Proc. Natl. Acad. Sci. USA, 87:9524-9528 (1990).
Kim et al., Cell, 87:343-355 (1996).
Kolykhalov et al., J. Virol., 74(4):2046-2051 (2000).
Kolykhalov et al., Science, 277:570-574 (1997).
Krieger et al., J. Virol., 75(10):4614-4624 (2001).
Lahm et al., Curr. Drug Targets, 3:281-296 (2002).
Lai et al., Clin. Infect. Dis., 36:687-696 (2003).
Lamarre et al., Nature, 426:186-189 (2003).
Lin et al., J. Biol. Chem., 279(17):17508-17514 (2004).
Lin et al., J. Virol., 68(12):8147-8157 (1994).
Lin et al., J. Virol., 69(7):4373-4380 (1995).
Lin et al., Proc. Natl. Acad. Sci. USA, 92:7622-7626 (1995).
Lohmann et al., J. Virol., 75(3):1437-1449 (2001).
Lohmann et al., Science, 285:110-113 (1999).
Love et al., Cell, 87(2):331-342 (1996).
Markland et al., Antimicrob. Agents Chemother., 44(4):859-866 (2000).
Migliaccio et al., J. Biol. Chem., 278(49):49164-49170 (2003).
Neumann et al., Science, 282:103-107 (1998).
Nguyen et al., Antimicrob. Agents Chemother., 47(11):3525-3530 (2003).
Pause et al., J. Biol. Chem., 278(22):20374-20380 (2003).
Pietschmann et al., J. Virol., 75(3):1252-1264 (2001).
Saito et al., Proc. Natl. Acad. Sci. USA, 87:6547-6549 (1990).
Takamizawa et al., J. Virol., 65(3):1105-1113 (1991).
Tanji et al., J. Virol., 69(3):1575-1581 (1995).
Tomei et al., J. Virol., 67(7):4017-4026 (1993).
Trozzi et al., J. Virol., 77(6):3669-3679 (2003).
Yan et al., Protein Sci., 7:837-847 (1998).

Affiliated with

Also associated with

Rating

HCV NS3-NS4A protease resistance mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HCV NS3-NS4A protease resistance mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HCV NS3-NS4A protease resistance mutants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4056236